NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 816 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,204,000 | -13.6% | 16,534 | -6.4% | 0.04% | -18.8% |
Q3 2016 | $1,394,000 | -10.4% | 17,657 | -6.3% | 0.05% | -14.3% |
Q2 2016 | $1,555,000 | +10.0% | 18,845 | -3.4% | 0.06% | -5.1% |
Q1 2016 | $1,413,000 | -24.1% | 19,505 | -9.9% | 0.06% | -30.6% |
Q4 2015 | $1,862,000 | +64.5% | 21,637 | +75.7% | 0.08% | -4.5% |
Q3 2015 | $1,132,000 | -65.9% | 12,313 | -63.5% | 0.09% | -62.3% |
Q2 2015 | $3,319,000 | +8.6% | 33,749 | +8.9% | 0.24% | +10.3% |
Q1 2015 | $3,057,000 | +36.8% | 31,005 | +28.5% | 0.21% | -11.9% |
Q4 2014 | $2,235,000 | -6.2% | 24,125 | -4.7% | 0.24% | -15.3% |
Q3 2014 | $2,384,000 | +20.4% | 25,323 | +15.8% | 0.29% | +8.3% |
Q2 2014 | $1,980,000 | -56.8% | 21,876 | -59.4% | 0.26% | -20.4% |
Q1 2014 | $4,584,000 | +150.2% | 53,908 | +136.5% | 0.33% | +18.9% |
Q4 2013 | $1,832,000 | +8.9% | 22,795 | +3.9% | 0.28% | -4.8% |
Q3 2013 | $1,683,000 | +15.6% | 21,939 | +6.6% | 0.29% | +0.7% |
Q2 2013 | $1,456,000 | – | 20,590 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |